Is Now the Time to Invest in Immunic Inc. (NASDAQ:IMUX)?

Is Now the Time to Invest in Immunic Inc. (NASDAQ:IMUX)?


The Immunic Inc. (IMUX) shares are trading at higher $15.67 and the avg recommendation for the stock is Strong Buy.

To add more color to this target, the company’s high over the last year is $19.05 and the low is $4.19. Over the last 52 weeks, IMUX is down -17.74% while the S&P 500 is down -2.55%. The catalyst for this interesting swing was the company’s recent earnings report.

A Notable Earnings Report

In the last quarter, IMUX reported a profit of $0.53 million. Immunic Inc. also saw revenues increase to $9.01 million. In addition, IMUX has free cash flow of -$11.03 million as of 03-2020 The company’s EBITDA came in at -$9.0 million which compares well with its peers.

IMUX Return on Equity (ROE) is -65.50%, and its Return on Assets is -59.40%. All told, it is clear that, IMUX needs to be on your watchlist.

Find out when IMUX reaches critical levels. Subscribe to Right Now by entering your Email in the box below.

Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. IMUX has a short ratio of 0.23 and outstanding shares of 10.75M.

Company Outlook

IMUX has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 0.38 million and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at -3.88. Immunic Inc. IMUX also noted assets of $57.29 million at the end of the last quarter. Investors should also keep an eye on sector updates as IMUX has historically followed its peers on positive news.

All told, Immunic Inc. IMUX has strung together solid data and demonstrated underlying fundamentals. At its current valuation, IMUX represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.

Immunic Inc. IMUX is now commanding a market cap of 239.28M and a float of 7.65M. IMUX is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of IMUX stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in IMUX, either long or short, and we have not been compensated for this article.